4-Methylcinnamic acid
Names
[ CAS No. ]:
1866-39-3
[ Name ]:
4-Methylcinnamic acid
[Synonym ]:
4-Methylciamic acid
BASF Luwipal 044
3-(4-methylphenyl)-2-propenoic acid
3-(p-Tolyl)acrylic acid
3-(4-Methylphenyl)acrylic acid
trans-4-methylcinnamic acid
3-P-TOLYL-ACRYLIC ACID
(2E)-3-(4-Methylphenyl)acrylic acid
(2E)-3-(4-methylphenyl)prop-2-enoic acid
4-MethylcinnaMic Acid
P-methycinnamic acid
2-Propenoic acid, 3-(4-methylphenyl)-, (2E)-
p-Methyl cinnamic acid
P-METHYLCINNAMIC ACID
2-Propenoic acid, 3-(4-methylphenyl)-
MFCD00002697
RARECHEM BK HC T309
EINECS 217-479-9
Biological Activity
[Description]:
[Related Catalog]:
[References]
Chemical & Physical Properties
[ Density]:
1.1±0.1 g/cm3
[ Boiling Point ]:
300.6±11.0 °C at 760 mmHg
[ Melting Point ]:
196-198 °C(lit.)
[ Molecular Formula ]:
C10H10O2
[ Molecular Weight ]:
162.185
[ Flash Point ]:
206.1±10.2 °C
[ Exact Mass ]:
162.068085
[ PSA ]:
37.30000
[ LogP ]:
2.87
[ Vapour Pressure ]:
0.0±0.7 mmHg at 25°C
[ Index of Refraction ]:
1.603
MSDS
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Hazard Codes ]:
Xi: Irritant;
[ Risk Phrases ]:
R36/37/38
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ HS Code ]:
2916399090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2916399090
[ Summary ]:
2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
Articles
Bioorg. Med. Chem. 17 , 896-904, (2009)
This paper reports a QSAR study for predicting the complexation of a large and heterogeneous variety of substances (233 organic compounds) with beta-cyclodextrins (beta-CDs). Several different theoret...
Structure-activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A).Bioorg. Med. Chem. Lett. 21 , 2736-9, (2011)
Nicotinic acid (niacin) has been used for decades as an antidyslipidemic drug in man. Its main target is the hydroxy-carboxylic acid receptor HCA2 (GPR109A), a G protein-coupled receptor. Other acids ...